MAFFEZZOLI, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 125
NA - Nord America 71
AS - Asia 64
AF - Africa 7
Totale 267
Nazione #
US - Stati Uniti d'America 71
IT - Italia 70
SG - Singapore 38
IE - Irlanda 23
CN - Cina 21
FR - Francia 15
DE - Germania 6
MA - Marocco 6
SE - Svezia 5
IN - India 4
AT - Austria 2
FI - Finlandia 2
CI - Costa d'Avorio 1
ES - Italia 1
PH - Filippine 1
RU - Federazione Russa 1
Totale 267
Città #
Singapore 30
Dublin 23
Boardman 20
Marseille 15
Milan 15
Ashburn 14
Parma 13
Shanghai 12
Modena 7
Beijing 6
Meknes 6
Bologna 5
Aachen 3
Brescia 3
Scandiano 3
Busto Arsizio 2
Felino 2
Los Angeles 2
Pune 2
Sant'Ambrogio di Valpolicella 2
Santa Clara 2
Vienna 2
Abidjan 1
Ancona 1
Castel di Lama 1
Chennai 1
Cologno Monzese 1
Desio 1
Helsinki 1
Kolkata 1
Leipzig 1
Magdeburg 1
Montecassiano 1
Moscow 1
Nuremberg 1
Padova 1
Soliera 1
Totale 204
Nome #
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 39
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 37
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 36
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 26
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 22
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 14
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 12
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 12
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 12
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 12
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 11
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 10
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 10
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 9
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study 8
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. 8
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 6
Totale 284
Categoria #
all - tutte 1.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/2024121 0 8 4 3 14 13 13 9 16 9 15 17
2024/2025102 7 36 44 15 0 0 0 0 0 0 0 0
Totale 284